HEALTH-RELATED QUALITY-OF-LIFE OUTCOMES 4-YEARS AFTER TREATMENT WITH VALOCTOCOGENE ROXAPARVOVEC

Objectives: Valoctocogene roxaparvovec, a gene therapy for severe Hemophilia A (HA), helps prevent bleeding by providing the body with genetic instructions for making factor VIII (FVIII) protein. We report findings from the GENEr8-1 study 4-years after participants received valoctocogene roxaparvove...

Full description

Bibliographic Details
Published in:	Hematology, Transfusion and Cell Therapy
Main Authors:	FP Careta, B Madan, MC Ozelo, G Kenet, S Chou, S Pipe, A Leavitt, A Ruiz, E Dashiell-Aje, J Mahlangu
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924013051

Similar Items

EFFICACY AND SAFETY OF VALOCTOCOGENE ROXAPARVOVEC 4 YEARS AFTER GENE TRANSFER IN GENER8-1
by: MC Ozelo, et al.
Published: (2024-10-01)

BLEEDING, FVIII ACTIVITY, AND SAFETY 3 YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC: RESULTS FROM GENER8-1
by: MC Ozelo, et al.
Published: (2023-10-01)

Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial
by: Andrew D. Leavitt, et al.
Published: (2024-11-01)

A SIMULATION STUDY TO PROVIDE GUIDANCE FOR INDIVIDUALS TRANSITIONING FROM EMICIZUMAB TO VALOCTOCOGENE ROXAPARVOVEC
by: W Kuwabara, et al.
Published: (2023-10-01)

BLEEDING RATE, FVIII UTILIZATION, CORTICOSTEROID USE, QUALITY OF LIFE AND SAFETY 4-YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC IN A BRAZILIAN COHORT: RESULTS FROM GENER8-1
by: MC Ozelo, et al.
Published: (2024-10-01)

O MAIS NOVO MEDICAMENTO PARA HEMOFILIA A: TERAPIA GÊNICA COM VALOCTOCOGENE ROXAPARVOVEC
by: LP Baião, et al.
Published: (2024-10-01)

QUANTITATIVE PHARMACOKINETIC MODEL TO CHARACTERIZE AND EXTRAPOLATE LONG-TERM FVIII ACTIVITY LEVELS IN PATIENTS WITH SEVERE HEMOPHILIA A TREATED WITH VALACTOCOGENE ROXAPARVOVEC
by: L Loureiro, et al.
Published: (2023-10-01)

Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials
by: Kenet G, et al.
Published: (2023-06-01)

Guidelines for management of hemophilia—why, what, and how?
by: Alok Srivastava, et al.
Published: (2025-05-01)

Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy: a post hoc analysis of the GENEr8-1 phase III trial
by: Doris V. Quon, et al.
Published: (2024-12-01)

Allyson Hobbs, A Chosen Exile : A History of Racial Passing in American Life
by: Lawrence Aje
Published: (2017-09-01)

Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
by: Robert F. Sidonio, Jr., et al.
Published: (2025-05-01)

Variables associated with surgeons’ expectations of lumbar surgery on patients’ reported outcomes of 2-years
by: R. Duculan, et al.
Published: (2024-01-01)

INTEGRAÇÃO ENTRE OS CENTROS DE TRATAMENTO DE HEMOFILIA E PACIENTES COMO FORMA DE AUMENTAR A ADESÃO AO TRATAMENTO
by: R. Pereira, et al.
Published: (2020-11-01)

GLOBAL COMPARATIVE ANTITHROMBIN-FIELD STUDY: IMPACT OF LABORATORY ASSAY VARIABILITY ON THE ASSESSMENT OF ANTITHROMBIN ACTIVITY MEASUREMENT
by: E Seth-Chhabra, et al.
Published: (2024-10-01)

SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE)
by: Guy-Young, et al.
Published: (2024-10-01)

Stress timing, trauma exposure, and family resilience differentially affect internalizing and externalizing symptoms at 3, 5, and 7 years of age
by: Viviane Valdes, et al.
Published: (2024-10-01)

Offender eLearning: A systematic literature review on re-entry, recidivism, and life after prison
by: Gilbert Mahlangu, et al.
Published: (2023-12-01)

Les politiques publiques de peuplement de la Caroline du Sud au prisme de la servitude sous contrat et de l’esclavage, 1670-1776
by: Lawrence Aje
Published: (2018-12-01)

Fugitive Slave Narratives and the (Re)presentation of the Self? The Cases of Frederick Douglass and William Brown
by: Lawrence Aje
Published: (2014-11-01)

L’évolution de la perception de la France et des français en Caroline du Sud à l’heure des révolutions française et de Saint-Domingue 1789-1804
by: Lawrence Aje
Published: (2012-12-01)

Health enhancing behaviors in early adolescence: an investigation of nutrition, sleep, physical activity, mindfulness and social connectedness and their association with psychological distress and wellbeing
by: Kassie Bromley, et al.
Published: (2024-09-01)

Hemophilia gene therapy knowledge and perceptions: Results of an international survey
by: Flora Peyvandi, et al.
Published: (2020-05-01)

THREE NEWSPAPERS’ COVERAGE OF INTIMATE PARTNER VIOLENCE AGAINST WOMEN IN NIGERIA, 2015-2017
by: Aje-Ori Agbese
Published: (2021-02-01)

Roles played by Nigerian YouTube micro-celebrities during the COVID-19 pandemic
by: Aje-Ori Agbese
Published: (2022-12-01)

Self-Reported Quality of Life Outcomes in Aphasia Using Life Participation Approach Values: 1-Year Outcomes
by: Michelle Armour, MS, CCC-SLP, et al.
Published: (2019-12-01)

Acute methemoglobinemia induced by dapsone
by: Trindade MAB, et al.
Published: (2008-11-01)

Entropic Equilibria Selection of Stationary Extrema in Finite Populations
by: Marc Harper, et al.
Published: (2018-08-01)

Factors associated with disease knowledge and attitude among ambulatory patients with type 2 diabetes – a multicenter study
by: Akinniyi A. Aje, et al.
Published: (2024-08-01)

Political Economy of Public Health
by: Judith W. Leavitt, et al.
Published: (2012-06-01)

Prognostic awareness and its association with health outcomes in the last year of life
by: Semra Ozdemir, et al.
Published: (2023-02-01)

High-throughput analysis of single human cells reveals the complex nature of DNA replication timing control
by: Dashiell J. Massey, et al.
Published: (2022-05-01)

A Patent Problem – When the Misapplication of Law Collides with an Error of Law: Villa Crop Protection (Pty) Ltd v Bayer Intellectual Property GmbH 2023 4 BCLR 461 (CC)
by: Nomthandazo Mahlangu
Published: (2025-07-01)

Recombinant factor VIIa: new insights into the mechanism of action through product innovation
by: Miguel A. Escobar, et al.
Published: (2025-01-01)

Equitable Mindfulness: A Framework for Transformative Conversations in Higher Education
by: Tiara A. Cash, et al.
Published: (2021-06-01)

Pagoda Data Management and Metadata Requirements for Libraries in Myanmar
by: Tin Tin Pipe, et al.
Published: (2023-09-01)

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies
by: Pratima Chowdary, et al.
Published: (2022-07-01)

Athletes’ religiosity: How it plays a role in athletes’ anxiety and life satisfaction
by: Tri S. Guntoro, et al.
Published: (2022-11-01)

Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment
by: Zachary A. Seymour, et al.
Published: (2022-09-01)

Previous hip or knee arthroplasty is associated with less favorable patient-reported outcomes of lumbar surgery
by: R. Duculan, et al.
Published: (2024-01-01)